Frequency-locked integrated CMOS oscillator design with resistive reference
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
The purpose of this thesis is to introduce a design for a CMOS oscillator, that is practically insensitive to temperature and line voltages and conservative in power consumption.Also presented are the details of a band-gap reference voltage reference and a beta-multiplier current reference as needed for the proper operation of the oscillator. Design and characterization of the proposed oscillator has been performed for XFAB XH018, 0.18 μm CMOS technology. The output of the oscillator provides a square wave of 545.5 kHz at room temperature with typical conditions. Oscillator output has achieved stable frequency within the temperature range -40 C 85 C and for +- 5 percent line voltage variation. The circuit satisfies the specifications by consuming only 5 μWand not more than 0.65 percent frequency variation. The design has also been verified in all process corners and distribution in process and matching for 3 sigma.
Author
Taner Barışık
Institution
How to Cite
Taner Barışık (Master Thesis). Frequency-locked integrated CMOS oscillator design with resistive reference, 2019, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)